BBBY - Bed Bath & Beyond Inc.
9.37 +0.01 (0.11%)
After hours: 7:35PM EDT
| Previous Close | 9.90 |
| Open | 9.90 |
| Bid | 9.36 x 900 |
| Ask | 9.39 x 29200 |
| Day's Range | 9.33 - 9.98 |
| 52 Week Range | 9.33 - 19.59 |
| Volume | 7,828,776 |
| Avg. Volume | 5,263,125 |
| Market Cap | 1.196B |
| Beta (3Y Monthly) | 1.59 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.18 |
| Earnings Date | Sep 24, 2019 - Sep 30, 2019 |
| Forward Dividend & Yield | 0.68 (6.97%) |
| Ex-Dividend Date | 2019-09-12 |
| 1y Target Est | 14.31 |
- Barrons.com•2 days ago
Why Stocks Are Still the Best Investment, Even After a 10-Year Run
Low growth, low inflation, and low interest rates are the perfect ticket for more market gains. Plus, Berkshire Hathaway’s frustrated shareholders
- American City Business Journals•3 days ago
PHOTOS: Charlotte area's top CFOs take spotlight at CBJ awards event
The Charlotte Business Journal honored this area's top finance leaders at its 11th annual CFO of the Year Awards event held at The Westin Charlotte in uptown on Thursday evening.
- TheStreet.com•3 days ago
You Won't Sleep Easy With Bed Bath & Beyond
Stocks with high dividend yields have great appeal for income investors. Stocks might have a high dividend yield, because their stock price has collapsed, which is a sign of trouble. An example of this is retailer Bed Bath & Beyond , which sports a dividend yield above 6%.
- InvestorPlace•4 days ago
3 Stocks That Look Like Death
The flurry of new highs notched by the S&P 500 is perhaps the clearest evidence of the decade-long golden age stocks we've been living in. Since the disastrous days of '08 and bottom carved in the Spring of '09, equities have grown 343%. But not all companies have been boosted during the buying binge. Some sad saps remain stocks to sell.Today we'll highlight three such losers.These stocks to sell weren't hard to find. Indeed, in a day of high flying equities tagging record-setting prices, all you have to do is look for the few stocks that are hitting new lows. There's a stink about them. Maybe they have deteriorating fundamentals. Or perhaps they find themselves in an out-of-favor sector. In any case, they're worth steering clear. Or you could deploy bearish trades to profit from their pain.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks Top Investors Are Buying Now Let's take a closer look at three deathly looking stocks to sell. Baidu (BIDU) Click to Enlarge Source: ThinkorSwim Since peaking last year at $284.22, Baidu (NASDAQ:BIDU) shares are down over 53%. The unwinding accelerated after May's dismal earnings report sent the shares plunging around 20% amid massive volume. Since then, BIDU stock has proven altogether unable to lift itself from the mat.And with the specter of another certain earnings announcement looming later this month, I think the selling could begin anew as shareholders who were holding out for a recovery finally jump ship.To bank on pre-earnings jitters, we could buy put options. The Aug $110 puts can be purchased for around $3.80 and offer a lower cost and limited risk way to speculate on additional weakness. 3 Stocks to Sell: Bed Bath & Beyond (BBBY) Click to Enlarge Source: ThinkorSwim Remember the powerful recovery Bed Bath & Beyond (NASDAQ:BBBY) staged over the first four months of the year? We're talking about the robust 87% ramp that pulled-in bargain hunters and spectators willing to bet on a turnaround.Well, it's gone. All of it.And this week, BBBY stock officially broke below the December low that marked the beginning of its once-promising ascent. That means every single person who got suckered into banking on the resurrection is now cursed with a losing position. And they're all likely sellers at higher prices, which is otherwise known as overhead supply.Couple the flawed fundamentals with terrible technicals and you have a toxic brew pointing toward lower prices.Unfortunately, with BBBY already down sharply after last week's earnings release, it's tough to recommend new bear trades here. But I would be a seller into any strength. * 3 Food Stocks to Buy for Fast and Big Profits The depths beckon. 3 Stocks to Sell: Halliburton (HAL) Click to Enlarge Source: ThinkorSwim Oil stocks have been poison to portfolios in recent years. And perhaps none best illustrates the damage inflicted than Halliburton (NYSE:HAL). Just last year the oil service titan was flirting with $60. Now it's threatening to break into the teens.The downtrend has taken a few pit stops along the way, but overall the descent has been relentless. Its latest two-month pause just gave way to renewed selling, and this morning HAL stock is working on its fifth straight down day. The next earnings report is right around the corner on July 22nd and could provide some relief, but I doubt it.If you're willing to bet with bears into the event, then buy the Sep $22.50/$20 bear put for around $1.15.As of this writing, Tyler Craig didn't hold a position in any of the aforementioned securities. Check out his recently released Bear Market Survival Guide to learn how to defend your portfolio against market volatility. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks Top Investors Are Buying Now * The 10 Best Cryptocurrencies to Keep on Your Radar * 7 Marijuana Penny Stocks That Could Triple (But You Won't Make Money) The post 3 Stocks That Look Like Death appeared first on InvestorPlace.
- Zacks•4 days ago
Can Value Investors Pick Bed Bath & Beyond (BBBY) Stock Now?
Let's see if Bed Bath & Beyond (BBBY) stock is a good choice for value-oriented investors right now from multiple angles.
- Motley Fool•5 days ago
What Bed Bath & Beyond Wants Investors to Know
On the latest earnings call, the struggling retailer's executives broke down the details of another difficult quarter.
- Motley Fool•6 days ago
With Sharks Circling Bed Bath & Beyond, It's Time Investors Checked Out
The latest earnings report for the home goods retailer points to a slow-spiral death story in the making.
- Simply Wall St.•6 days ago
How Financially Strong Is Bed Bath & Beyond Inc. (NASDAQ:BBBY)?
Investors are always looking for growth in small-cap stocks like Bed Bath & Beyond Inc. (NASDAQ:BBBY), with a market...
- GuruFocus.com•6 days ago
'No Options at All'
Some thoughts on the capital allocation issues faced by businesses with structural headwinds Continue reading...
- PR Newswire•6 days ago
Lemelson Capital Management Announces 1H, 2019 Financial Results for The Amvona Fund, LP
Short position in Ligand pharmaceuticals, long position in Geospace Technologies, contribute to 70.27 percent net return in 1H, 2019 SHELBURNE, Vt ., July 16, 2019 /PRNewswire/ -- Lemelson Capital Management, ...
- Motley Fool•7 days ago
Bed Bath & Beyond, We're Still Waiting for That Turnaround
The beleaguered home goods retailer still has time to turn the ship around, but the pressure's only going up.
- Motley Fool•8 days ago
Bed Bath & Beyond Stumbled Again Last Quarter
The home furnishings retailer's 6.6% sales drop makes its financial targets for fiscal 2019 seem rather unrealistic.
- Motley Fool•9 days ago
3 Reasons Bed Bath & Beyond Is Still a Value Trap
This retailer’s stock is dirt cheap, but its core business is sill crumbling.
- Motley Fool•9 days ago
Bed Bath & Beyond Takes Another Massive Charge in Q1
The home furnishings retailer has written off nearly $1 billion over the past two quarters.
- Motley Fool•9 days ago
Bed Bath & Beyond’s Struggles Deepen
The growth outlook just got cloudier for this specialty retailer.
- GuruFocus.com•10 days ago
Bed Bath & Beyond's 1st-Quarter Financials: What You Need to Know
Comparable store sales dropped 6.6% year over year Continue reading...
- InvestorPlace•10 days ago
Friday’s Vital Data: Bed Bath & Beyond, CVS and Merck
In early morning trading, futures on the Dow Jones Industrial Average are up 0.29%, and S&P 500 futures are higher by 0.22%. Nasdaq-100 futures have added 0.20%.Source: Shutterstock In the options pits, calls continued their usual leadership role on Thursday, while overall volume settled to average levels. Specifically, about 18 million calls and 14.4 million puts changed hands on the session.Meanwhile, over at the CBOE, the single-session equity put/call volume ratio normalized after Wednesday's super low reading. The metric climbed back to 0.61 to end in the location of the 10-day moving average.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOptions traders swarmed the following three stocks. Bed Bath & Beyond (NYSE:BBBY) continued its trend of earnings deterioration with weak numbers for the fiscal first-quarter. Merck (NYSE:MRK) and CVS Health (NYSE:CVS) both saw sharp moves following news that the White House was ending its drug rebate plans.Let's take a closer look: Bed Bath & Beyond (BBBY)A quick Google search following this week's earnings release for ailing retailer, Bed Bath & Beyond, reveals a litany of ominous-sounding headlines. And, well, they're all probably justified. For the fiscal first-quarter, the company posted a loss of $2.91 per share. After adjusting for miscellaneous items, however, earnings came in at 12 cents per share, marking a 68% decline. Comps were down 6.6%, and revenue grew to $2.57, which was well below last year's $2.75 billion in the same quarter.Sellers took to the streak driving BBBY stock as low as $10.43 before a rapid recovery carried it back near the high of the day. The chart continues to look like garbage, warning anyone who cares about technical analysis to stay far away. That said, the intraday rebound was impressive and could deliver some short-term relief. * 7 Short Squeeze Stocks With Big Upside Potential On the options trading front, puts were all the rage. Total activity ballooned to 777% of the average daily volume, with 108,356 contracts traded; 70% of the trading came from call options alone.The expected move ahead of earnings was $1.54 or 13.3%, so with the stock rallying back to near unchanged on the session, anyone who shorted volatility before the report and held steady through the morning drop came out a big winner. CVS Health (CVS)CVS Health has been in decline for years, but scored a rare win yesterday after the White House halted plans that "would have curtailed rebates that drug manufacturers pay pharmacy benefit managers (PBMs) in return for winning placement of high-priced products on lists of drugs that insurers cover with affordable co-pays."Although CVS stock closed up 4.68% on the session, it was mostly a sell-the-news reaction. It was up as much as 8.6% before sellers swarmed and capitalized on the gift. The chart still looks terrible, but Thursday's jump did complete a five-month basing pattern, so there is a chance that a short-term bottom has been put in place.On the options trading front, optimism drove traders into call options throughout the session. By day's end, activity grew to 539% of the average daily volume, with 170,938 total contracts traded. Calls claimed 66% of the session's sum.Implied volatility jumped to 31% or the 41st percentile of its one-year range. Premiums are now pricing in daily moves of $1.13 or 1.9%. Merck (MRK)CVS Health wasn't the only stock impacted by the White House announcement. Companies that manufacture and sell drugs like Merck were whacked after the news. Barrons has an insightful take you can find here. * 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond The single day 4.5% drop took some $7 billion off the market cap of MRK stock and pushed it back below its 50-day moving average. The uptrend is now on shaky footing, and the stock is in technical no man's land. If the weakness persists, use $77 as your first downside target. It would take a recovery to $85 before negating the bearish signals created by Thursday's swoon.On the options trading front, put popularity only slightly edged out calls. By the closing bell, activity climbed to 392% of the average daily volume, with 100,295 total contracts traded. Puts accounted for 52% of the take.The plunge did light a fire under implied volatility, driving the measure up to 24% or the 52nd percentile of its one-year range. Premiums are officially pumped, suggesting short options strategies are the way to go if you're inclined to trade here.As of this writing, Tyler Craig didn't hold a position in any of the aforementioned securities. Check out his recently released Bear Market Survival Guide to learn how to defend your portfolio against market volatility. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Buy for Less Than Book * 7 Marijuana Stocks With Critical Levels to Watch * The 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond The post Friday's Vital Data: Bed Bath & Beyond, CVS and Merck appeared first on InvestorPlace.
- American City Business Journals•10 days ago
CFO of the Year 2019: How these financial execs are guiding their companies through trials, triumphs
This CBJ awards program recognizes financial leaders across the region who have set their companies up for success.
- American City Business Journals•10 days ago
CFO of the Year: How retirement landed Mary Winston at the helm of Bed, Bath & Beyond
Despite deciding to "semi-retire" following her tenure as CFO at Family Dollar, Mary Winston's work in consulting and corporate board governance landed her at the helm of a Fortune 500 retailer.
- Thomson Reuters StreetEvents•10 days ago
Edited Transcript of BBBY earnings conference call or presentation 10-Jul-19 9:00pm GMT
Q1 2019 Bed Bath & Beyond Inc Earnings Call
- TheStreet.com•10 days ago
Replay: Jim Cramer on the Markets, Oil, and Bed Bath & Beyond
Jim Cramer weighs in on Bed Bath & Beyond's quarter and what he expects from day two of Federal Reserve Chairman Jay Powell's testimony in front of the House Financial Committee.
- Motley Fool•10 days ago
3 Retailers Hoping to Copy the Success of Amazon Prime
Premium customer loyalty programs are all the rage, as RH, Bed Bath & Beyond, and Lululemon have discovered.
- Yahoo Finance Video•10 days ago
Here's why Brooklinen wants to make its competition with brands like Bed Bath and Beyond stronger
Brooklinen Founder Rich Fulop sits down with Yahoo Finance's Julie Hyman, Adam Shapiro, and Pras Subramanian to discuss his company's direct-to-consumer approach to selling bedding accessories and loungewear.
- Yahoo Finance Video•10 days ago
What Bed Bath & Beyond's disappointing sales means for its future
Looper Capital Markets Managing Director Anthony Chukumba discusses what's next for Bed Bath & Beyond after their disappointing earnings with Yahoo Finance's Julie Hyman and Adam Shapiro.
